Clinical Trial Update: Single Site, Single Subject, Treatment IND With Mannkind Corporation's Technosphere Inhalation System [NA]

View source ↗

Summary

A single-site, single-subject treatment IND trial using MannKind's Technosphere Inhalation System for diabetes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes

Drugs mentioned

• Technosphere Inhalation System

Snippet

Sponsor: South Orange County Endocrinology | Conditions: Diabetes | NA | Status: WITHDRAWN